<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: Gα(q) and Gα(11) signalling pathways contribute to <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">cardiac diseases</z:e> such as <z:mpath ids='MPATH_159'>hypertrophy</z:mpath> and <z:hpo ids='HP_0011675'>arrhythmia</z:hpo>, but their role in cardiac myocytes from healthy hearts has remained unclear </plain></SENT>
<SENT sid="1" pm="."><plain>We aimed to investigate the contribution of Gα(q) and Gα(11) signalling to the basal properties of ventricular myocytes </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS AND RESULTS: We created a conditional Gα(q) knockout (KO) after <z:chebi fb="3" ids="41774">tamoxifen</z:chebi> injection into gnaq(flox/flox) gna11(-/-) α-MHC Cre(tg/0) mice and found alterations in the electrophysiological and Ca(2+) handling properties of ventricular myocytes using patch-clamp and Fura-2 video imaging </plain></SENT>
<SENT sid="3" pm="."><plain>To reveal the genuine effects of protein KO, we investigated the individual contributions of (i) <z:chebi fb="3" ids="41774">tamoxifen</z:chebi> injection, (ii) Cre recombinase expression, (iii) Gα(11) KO, and (iv) Gα(q) KO </plain></SENT>
<SENT sid="4" pm="."><plain>Profound and persistent alterations in myocyte properties occurred following the <z:chebi fb="3" ids="41774">tamoxifen</z:chebi> injection alone </plain></SENT>
<SENT sid="5" pm="."><plain>Consequently, we used the presence or absence of Cre recombinase expression as the determinant for the Gα(q) KO </plain></SENT>
<SENT sid="6" pm="."><plain>Myocytes from the Gα(q) and/or Gα(11) KO mice displayed genuine alterations in the action potentials, membrane capacitance, membrane currents, and Ca(2+) handling (amplitude, post-rest behaviour, and Ca(2+) removal processes) </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: We conclude that, in a <z:e sem="disease" ids="C1519606" disease_type="Experimental Model of Disease" abbrv="">transgenic model</z:e>, the role of Gα(q) can be best studied using Cre recombinase expression as the molecular determinant for Gα(q) KO rather than <z:chebi fb="3" ids="41774">tamoxifen</z:chebi>/miglyol injection </plain></SENT>
<SENT sid="8" pm="."><plain>While excessive hormonal stimulation of the Gα(q)/Gα(11) signalling pathways plays an essential role in <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">cardiac diseases</z:e>, we propose that the persistent low-level stimulation of these pathways by Gα(q)/Gα(11) activation is instrumental in the physiological behaviour of ventricular myocytes </plain></SENT>
</text></document>